Report
Dave Nicoski ...
  • Ross LaDuke
EUR 48.00 For Business Accounts Only

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Underlyings
Alphabet Inc. Class A

Alphabet is a holding company. Through its subsidiaries, the company is engaged in a collection of businesses, which its primary business is Google. The company reports all non-Google businesses collectively as Other Bets. Google's main products and platforms are Android, Chrome, Gmail, Google Drive, Google Maps, Google Play, Search, and YouTube. The company also provides advertisers with tools that help them attribute and measure their advertising campaigns. In addition, Other Bets includes Access, Calico, CapitalG, GV, Verily, Waymo, and X, among others. Other Bets primarily engages in the sales of internet and TV services through Access as well as licensing and research and development services through Verily.

Apellis Pharmaceuticals

Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on treating disease through the inhibition of the complement system, which is a component of the immune system, at the level of C3, the central protein in the complement cascade. The company's clinical program targets C3 with Phase 3 clinical trials of its main product candidate, APL-2, in multiple indications. APL-2 has the potential to be a treatment that address the limitations of existing treatment options or provide a treatment option. The company is also conducting a Phase 2 trial of APL-2 in glomerular diseases, including C3 glomerulopathy, IgA nephropathy, primary membranous nephropathy and lupus nephritis.

Athene Holding Ltd. Class A

Axon Enterprise Inc

Axon Enterprise is provider of law enforcement technology solutions. The company's operations are comprised of two reportable segments: TASER, which is focused on development, manufacture and sale of conducted energy weapons, also known as conducted energy devices, which the company sells under its brand name, TASER; and software and sensors, which is focused on-officer body (Axon Body and Flex) and in-car (Axon Fleet) cameras as well as cloud-based digital evidence management software (Evidence.com), as well as develops, manufactures and sells hardware and cloud-based software solutions that enable law enforcement to capture, store, manage, share and analyze video and other digital evidence.

CarMax Inc.

CarMax is a holding company. Through its subsidiaries, the company is engaged as a retailer of used vehicles. The company operates in two segments: CarMax Sales Operations, which sells used vehicles, purchases used vehicles from customers and other sources, sells related products and services, and arranges financing options for customers; and CarMax Auto Finance, which consists of finance operation that provides vehicle financing to customer buying retail vehicles from the company The company's products and services include retail merchandising, wholesale auctions, extended protection plans, reconditioning and service, and customer credit.

Cartera Mobiliaria S.A.

Cerence

Cerence is primarily engaged in providing automotive manufacturers and their suppliers virtual assistants and connected car services built on its voice recognition and natural language understanding technologies. The company is a provider of AI-powered assistants for connected and autonomous vehicles, including software platforms for building automotive virtual assistants, such as Hey BMW and Ni hao Banma. The company's principal offering is its software platform, which its customers use to build virtual assistants that can communicate, find information and take action across a variety of categories, including navigation, control, media, communication, information and tools.

Ciner Resources

Clearside Biomedical Inc

Clearside Biomedical is a biopharmaceutical company developing treatments that restore vision for people with back of the eye diseases. The company's suprachoroidal injection platform is a patented approach for delivering pharmacotherapy to the back of the eye via the suprachoroidal space (SCS). The company's key product candidate, XIPERE, is a proprietary, preservative-free suspension of the corticosteroid triamcinolone acetonide formulated for administration via suprachoroidal injection, for the treatment of macular edema related with uveitis. The company is also developing Axitinib for Suprachoroidal Injection for administration to the SCS as a long-acting therapy for wet age-related macular degeneration.

Ferroglobe PLC

Fortinet Inc.

Fortinet provides cybersecurity solutions. The company's product offerings consist of its FortiGate product family and its non-FortiGate products. The company's FortiGate hardware and software licenses are sold with a set of security services. These security services are enabled by FortiGuard, which provides threat research and artificial intelligence capabilities from a global cloud network to deliver protection services to each FortiGate appliance. The company's non-FortiGate products include the Fortinet Security Fabric (such as FortiAP, FortiAnalyzer, FortiSwitch and FortiManager), certain cloud security products (such as virtual machines and cloud services) and other products.

Grid Dynamics Holdings, Inc.

IDT Corp. Cl B

IDT operates primarily in the telecommunications and payment industries. The company has two reportable business segments: Telecom and Payment Services and net2phone. The company's Telecom and Payment Services segment provides retail telecommunications and payment offerings as well as wholesale international long-distance traffic termination. The company's net2phone segment provides unified cloud communications and telephony services to business customers.

IVERIC bio

IVERIC bio is a biopharmaceutical company focused on the discovery and development of treatment options for retinal diseases with unmet medical needs. The company is developing both therapeutics for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases. The company's product candidate Zimura, a complement inhibitor, is a chemically-synthesized, pegylated RNA aptamer. The company's clinical trials for Zimura include: OPH2003, for patients with geographic atrophy secondary to dry age-related macular degeneration; and OPH2005, for the treatment of Stargardt disease.

J. Alexander's Holdings

J Alexander's Holdings is a holding company. Through its subsidiaries, the company owns and operates complementary upscale dining restaurants including: J. Alexander's, Redlands Grill, Lyndhurst Grill, Overland Park Grill and Stoney River Steakhouse and Grill. The J. Alexander's menu features prime rib of beef; hardwood-grilled steaks, seafood and chicken; pasta; salads; soups; and assorted sandwiches, appetizers and desserts. Stoney River is an upscale steakhouse concept that seeks to provide the quality and service of fine dining steakhouses at a lower price point. Redlands Grill provides a range of contemporary American cuisine featuring expanded menu offerings on a seasonal or rotational basis.

Liberty Media Corporation Series A Liberty Formula One

Liberty Media owns interests in subsidiaries and other companies which are engaged in the media and entertainment industries. The company's businesses and assets include its consolidated subsidiaries Sirius XM Holdings Inc., which transmits music, sports, entertainment, comedy, talk, news, traffic and weather channels, as well as infotainment services, and the Braves Holdings, LLC, which is engaged in television and radio broadcasting, ticket sales and advertising and corporate sponsorship, and its equity affiliate Live Nation Entertainment, Inc., which is a live entertainment company. The company also owns a portfolio of minority debt and equity investments in media companies, including iHeart Media, Inc.

Lucira Health

Microsoft Corporation

Microsoft is a technology company. The company develops and supports software, services, devices, and solutions. The company provides an array of services, including cloud-based solutions as well as solution support and consulting services. The company also delivers relevant online advertising. The company's products include operating systems; cross-device productivity applications; server applications; business solution applications; desktop and server management tools; software development tools; and video games. The company also designs, manufactures, and sells devices, including personal computers, tablets, gaming and entertainment consoles, other devices, and related accessories.

OptimumBank Holdings

OptimumBank Holdings is a bank holding company. Through its subsidiary, OptimumBank (The Bank), the company provides a variety of community banking services to individual and corporate customers through its banking offices located in Broward County, FL. The Bank provides a range of consumer and commercial banking services including: demand interest-bearing and noninterest-bearing accounts, money market deposit accounts, negotiable order of withdrawal accounts, time deposits, Visa debit and automated teller machine cards, cash management, direct deposits, notary services, money orders, night depository, cashier's checks, domestic collections, and banking by mail.

Peabody Energy Corporation

Peabody Energy is a coal company, engaged in the mining of thermal coal for sale primarily to electric utilities and metallurgical coal for sale to industrial customers. The company owns interests in several coal mining operations located in the U.S. and Australia. The company has a majority interest in several of those mining operations and an equity interest in Middlemount Coal Pty Ltd. (Middlemount), which owns the Middlemount Mine in Queensland, Australia. In addition to its mining operations, the company markets and brokers coal from other coal producers, both as principal and agent, and trade coal and freight-related contracts through trading and business offices in the U.S., Australia, China, and the U.K.

Prothena Corp. Plc

Rafael Holdings Cl B

Rafael Holdings owns interests in commercial real estate assets and clinical stage pharmaceutical companies. The company's business consists of two reportable segments: Real Estate and Pharmaceuticals. The commercial real estate holdings consist of the building in Newark, NJ that serves as headquarters for the company and certain affiliated entities, car public garage, an office/data center building in Piscataway, NJ and a portion of a building in Israel. The pharmaceutical holdings include Rafael Pharmaceuticals, Inc., which is a clinical-stage, oncology-focused, pharmaceutical company and LipoMedix Pharmaceuticals Ltd., which is a clinical-stage oncological pharmaceutical company based in Israel.

Revolve Group

Revolve operates as an online fashion retailer. The company manufactures and sells a portfolio of approximately 45,000 apparel, footwear, accessories, and beauty styles under a range of established brands, as well as 19 owned brands.

Santander Consumer USA Holdings Inc.

Santander Consumer USA Holdings is a holding company, focused on vehicle finance and third-party servicing. The company is engaged in the indirect origination and securitization of retail installment contracts through manufacturer-franchised dealers in connection with their sale of new and used vehicles. Uder the Chrysler Agreement with FCA US LLC (FCA), the company operates as FCA's preferred provider for consumer loans, leases and Dealer Loans and provides services to FCA customers and dealers. These products and services include consumer retail installment contracts and leases, as well as Dealer Loans for inventory, construction, real estate, working capital and revolving lines of credit.

Translate Bio

Translate Bio is a clinical-stage messenger RNA (mRNA) therapeutics company. The company is engaged in developing medicines to treat diseases caused by protein or gene dysfunction. Using its proprietary mRNA therapeutic platform (MRT platform), the company creates mRNA that encodes functional proteins. The company is developing its MRT product candidate for the lung, MRT5005, for the treatment of cystic fibrosi, and MRT5201, for the treatment of ornithine transcarbamylase deficiency.

Transocean Ltd.

Tuscan Holdings

Upwork

UPWORK operates an online talent marketplace, which enables businesses to find and work with independent personnel. Freelancers on the company's platform include independent personnel and agencies of varying sizes. The company's marketplace offerings include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The company,'s Upwork Basic offering provides clients with access to freelance talent with verified work history on its platform and client feedback, the ability to match with the freelancers, and built-in collaboration features. The company's Upwork Plus provides all the product features of Upwork Basic, as well as access to personalized assistance, whether strategic or job-specific.

Workiva

Workiva is a provider of cloud-based solutions for connected data, reporting and compliance. The company's platform, Wdesk provides controlled collaboration, data linking, data integrations, granular permissions, process management and a full audit trail. Wdesk enables the company's users to collect, aggregate and prepare their unstructured and structured data in a cloud-based environment. Numbers, narrative, charts and graphics can be linked inside Wdesk. The company's Wdesk platform enables customers to collect, link, manage, report and analyze business data for a range of use cases across public and private companies, government agencies and higher-education institutions.

Provider
Vermilion Research
Vermilion Research

Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.

Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.

Analysts
Dave Nicoski

Ross LaDuke

Other Reports on these Companies
Other Reports from Vermilion Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch